Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated filings document the formal disclosures of a NYSE-listed ingredient solutions company with common stock registered under the ticker INGR. Its 8-K reports include operating results, financial-condition updates, dividend-related corporate actions, leadership changes, board appointments and governance matters.
The company's proxy materials cover director elections, executive compensation, board structure, shareholder voting items and non-management director compensation. Other filings describe capital-structure details for its common stock, exit or disposal activities, impairment charges, restructuring matters and risk disclosures connected to manufacturing operations and the company's plant-based ingredient portfolio.
Ingredion Incorporated reported a board change. On June 7, 2026, the Board elected Kenneth Escoe, age 51, to serve as a director with a term beginning July 1, 2026. The Board determined he qualifies as an independent director under New York Stock Exchange standards.
Escoe is Executive Vice President of Specialty Products at Illinois Tool Works Inc. and also serves on the Board of United Way of Metropolitan Chicago. He will receive the same cash and equity retainers as other non-management directors, including restricted stock units under the company’s stock incentive plan, and will sign the company’s standard director indemnification agreement.
Ingredion Incorporated has agreed to a recommended all-cash acquisition of Tate & Lyle PLC, offering 595 pence per share, implying total cash consideration of about £2.7 billion (approximately $3.6 billion) and an enterprise value of about £3.7 billion ($5.0 billion).
The deal, expected to close in the second half of 2027 via a UK court-sanctioned scheme of arrangement, includes permitted dividends of up to 20 pence per share and a c.59% premium to Tate & Lyle’s May 13, 2026 share price. Ingredion targets about $130 million in run‑rate cost synergies by 2030, with around $175 million in one-time costs, and plans to finance the transaction with cash, new debt and a fully committed $4.225 billion 364‑day bridge facility. Ingredion expects pro forma net leverage of roughly 3.0x at closing, aiming to reduce it to about 2.5x within around 18 months.
Seip David Eric reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president David Eric Seip received a grant of phantom stock under the company’s Non-Qualified Deferred Compensation Plan. The award covers 17.217 phantom stock units at a reference price of $101.44 per unit, each tied to one share of common stock. Following this grant, Seip holds a total of 13,200.4581 phantom stock units, which track the value of Ingredion’s common stock but are part of a deferred compensation arrangement rather than an open-market purchase.
Leonard Michael J reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc senior vice president and CIO Michael J. Leonard received a grant of 33.673 phantom stock units on May 29, 2026. The units were credited under the company's Non-Qualified Deferred Compensation Plan, using a reference price of $101.44 per share of common stock.
Following this award, Leonard has 1,649.130 phantom stock units credited to his account. Each phantom stock unit represents the right to receive one share of Ingredion common stock, aligning his compensation more closely with shareholder value over time.
Wilson Dwayne Andree reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Dwayne Andree Wilson received a grant of 1,797 restricted stock units as part of the company’s outside director annual equity retainer. The RSUs, which may be settled only in common shares on a one-for-one basis, vest on May 19, 2027. Following this award and related deemed dividend reinvestment, his direct holdings total 30,536.29 shares and RSUs.
Verduin Patricia reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc reported that director Patricia Verduin received a grant of 1,797 restricted stock units (RSUs) of common stock on May 20, 2026, as part of outside director compensation under the company’s Stock Incentive Plan. These RSUs relate to the 2026 annual equity retainer and a short transition period as the company shifts director stock compensation to a twelve‑month cycle aligned with the annual stockholder meeting. The RSUs settle in shares on a one‑for‑one basis and are scheduled to vest on May 19, 2027, subject to potential accelerated vesting upon retirement, death, disability, or a Change in Control. Following this award, Verduin directly holds 5,620 shares of common stock.
Uribe Jorge A. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Jorge A. Uribe received an equity award of 1,797 restricted stock units (RSUs) of common stock, valued at $107.34 per share. The RSUs were granted under Ingredion’s Stock Incentive Plan as part of the outside directors’ 2026 annual retainer and a transition period from April 1, 2026 to May 19, 2026. The RSUs can only be settled in shares on a one-for-one basis and will vest on May 19, 2027, subject to possible acceleration upon retirement, death, disability, or a Change in Control. Following this grant, Uribe directly holds 14,815.4677 shares and indirectly holds 6,449 shares through Cafedan Investments Ltd Trust.
Tanda Stephan B. reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Stephan B. Tanda received an equity award in the form of restricted stock units (RSUs) as part of the company’s 2026 outside director compensation. The Form 4 shows a grant of 1,797 shares of common stock-equivalent RSUs at a reference price of $107.34 per share, issued under the Ingredion Incorporated Stock Incentive Plan.
The RSUs may be settled only in shares of common stock on a one-for-one basis and will vest on May 19, 2027, with potential acceleration at the compensation committee’s discretion upon retirement, death, disability, or a Change in Control. Following this award, Tanda holds 1,797 common shares directly and 10,737 common shares indirectly through The Tanda Joint Living Trust.
Talbot Siobhan reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Siobhan Talbot reported receiving an equity award of 1,797 shares of common stock in the form of restricted stock units as part of the annual retainer for outside directors. The grant is valued at $107.34 per share and represents her entire reported direct holding after the award.
The RSUs were issued under the Ingredion Incorporated Stock Incentive Plan, reflecting a 2026 change from a calendar-year basis to a twelve‑month cycle aligned with the annual stockholder meeting. Each RSU settles into one share of common stock and is scheduled to vest on May 19, 2027, subject to possible accelerated vesting upon retirement, death, disability, or a Change in Control.
Suever Catherine A reported acquisition or exercise transactions in this Form 4 filing.
Ingredion Inc director Catherine A. Suever received an award of 1,797 restricted stock units (RSUs) linked to the company’s common stock on May 20, 2026. The RSUs were granted under Ingredion’s Stock Incentive Plan as part of the outside directors’ 2026 annual equity retainer, including a short stub period and a new twelve‑month cycle aligned with the annual stockholder meeting.
Each RSU will be settled in one share of common stock and is scheduled to vest on May 19, 2027, with potential accelerated vesting at retirement, death, disability, or a Change in Control. Some RSUs in the balance reflect deemed dividend reinvestment. Following this award, Suever directly holds 8,709.848 shares/RSUs in total.